about
Intermittent preventive treatment of malaria in pregnant women and infants: making best use of the available evidenceCombating poor-quality anti-malarial medicines: a call to actionTying malaria and microRNAs: from the biology to future diagnostic perspectivesResuscitating the Dying AutopsyChallenges and key research questions for yaws eradicationAntimalarial efficacy of piperaquine-based antimalarial combination therapies: facts and uncertaintiesA novel Plasmodium falciparum rhoptry associated adhesin mediates erythrocyte invasion through the sialic-acid dependent pathwaySafety of the RTS,S/AS02D candidate malaria vaccine in infants living in a highly endemic area of Mozambique: a double blind randomised controlled phase I/IIb trialGlucose-6-phosphate dehydrogenase deficiency, chlorproguanil-dapsone with artesunate and post-treatment haemolysis in African children treated for uncomplicated malariaEfficacy and safety of artemether-lumefantrine dispersible tablets compared with crushed commercial tablets in African infants and children with uncomplicated malaria: a randomised, single-blind, multicentre trialThe impact of a filariasis control program on Lihir Island, Papua New GuineaThe use of artemether-lumefantrine for the treatment of uncomplicated Plasmodium vivax malariaPaediatric pharmacovigilance: use of pharmacovigilance data mining algorithms for signal detection in a safety dataset of a paediatric clinical study conducted in seven African countriesStrategies for understanding and reducing the Plasmodium vivax and Plasmodium ovale hypnozoite reservoir in Papua New Guinean children: a randomised placebo-controlled trial and mathematical modelCharacterization of Vaginal Escherichia coli Isolated from Pregnant Women in Two Different African SitesHeterogeneity of G6PD deficiency prevalence in Mozambique: a school-based cross-sectional survey in three different regionsPlasmodium vivax malaria in Mali: a study from three different regionsThe role of age and exposure to Plasmodium falciparum in the rate of acquisition of naturally acquired immunity: a randomized controlled trialSafety, immunogenicity and duration of protection of the RTS,S/AS02(D) malaria vaccine: one year follow-up of a randomized controlled phase I/IIb trialG6PD deficiency in Latin America: systematic review on prevalence and variantsThe Burden of Cryptosporidium Diarrheal Disease among Children < 24 Months of Age in Moderate/High Mortality Regions of Sub-Saharan Africa and South Asia, Utilizing Data from the Global Enteric Multicenter Study (GEMS)Malaria epidemiology in Lihir Island, Papua New Guinea.Mycetoma caused by Nocardia yamanashiensis, Papua New Guinea.The effect of dosing strategies on the therapeutic efficacy of artesunate-amodiaquine for uncomplicated malaria: a meta-analysis of individual patient dataBaseline data of parasite clearance in patients with falciparum malaria treated with an artemisinin derivative: an individual patient data meta-analysis.Lower respiratory tract infections associated with rhinovirus during infancy and increased risk of wheezing during childhood. A cohort study.A 10 year study of the cause of death in children under 15 years in Manhiça, Mozambique.Insights into long-lasting protection induced by RTS,S/AS02A malaria vaccine: further results from a phase IIb trial in Mozambican children.Dihydroartemisinin-piperaquine and artemether-lumefantrine for treating uncomplicated malaria in African children: a randomised, non-inferiority trial.Continuous determination of blood glucose in children admitted with malaria in a rural hospital in MozambiqueHaemophilus ducreyi DNA is detectable on the skin of asymptomatic children, flies and fomites in villages of Papua New GuineaIn-Vivo Efficacy of Chloroquine to Clear Asymptomatic Infections in Mozambican Adults: A Randomized, Placebo-controlled Trial with Implications for Elimination StrategiesResponses to Bacteria, Virus, and Malaria Distinguish the Etiology of Pediatric Clinical PneumoniaSafety and tolerability of adjunctive rosiglitazone treatment for children with uncomplicated malariaProcalcitonin and C-reactive protein for invasive bacterial pneumonia diagnosis among children in Mozambique, a malaria-endemic area.Validity of a minimally invasive autopsy tool for cause of death determination in pediatric deaths in Mozambique: An observational study.Validity of a minimally invasive autopsy for cause of death determination in stillborn babies and neonates in Mozambique: An observational study.Host age and expression of genes involved in red blood cell invasion in Plasmodium falciparum field isolates.Association of severe malaria outcomes with platelet-mediated clumping and adhesion to a novel host receptor.Precisely Tracking Childhood Death
P50
Q21032450-5E265F9A-29C8-4EEF-B495-4AA819A5D9C0Q24658634-61721D57-0027-4C58-93BB-5BE16A4C2FADQ26765405-A99A6F69-7A89-4EA4-B383-26FD9B867D99Q26772243-6CC7EFBF-A653-4160-876E-1CB3F82F6B76Q26781437-6BB3117C-C74D-4562-9F76-C694EAF57795Q26866187-EAA181DE-836D-4CE6-ACB7-536331AC1BFCQ27230077-D11CB61B-87EB-4912-892B-AE1B31A51251Q28254031-37EE2840-2D75-4B37-AC24-146083BC9949Q28265711-74480F28-844E-4BE1-B7DE-0745BB35F447Q28297711-91B965AD-FC90-4258-B812-75733F1A9129Q28297711-946844C9-4149-4286-AC8A-34FD279F4E49Q28476658-DE259FAE-F973-4F3C-8A5B-E87E8979AC0BQ28478579-64354AEC-5E68-4E51-A4B6-979F1F16C499Q28538338-75E48315-041E-4E25-B3DF-361504625422Q28550515-B268C6CA-AEFC-4D56-B8C6-BBBF53A67BEFQ28552421-04F0A361-DF9B-4309-998B-BC33BDF5F4F8Q28559557-4D789F12-BBB4-4FCB-B681-006ADC84A6D9Q28709948-692A63CF-9597-4DDE-B632-D9EEA6BDAFBCQ28731458-CD64965B-7371-4E12-85C9-4CA5D9D29821Q28748565-1A373314-95CE-45A8-B996-9E524FF58F4DQ28748565-9EFC506F-5047-4D4E-8874-10AB073591EFQ29353696-F41B6247-DD69-4D65-95A6-533721DF774AQ30276745-FA0DB03B-362D-43A0-8F7A-61583B4E29C0Q30394036-8C921133-A833-49F1-968D-B8A0D8F9EF80Q30453946-260496BB-8EC7-40AF-B627-24697FD6E4D7Q30453946-544D31F7-D91D-416B-897A-08237C2E4AF7Q30936416-52E97EA5-7EB5-4BD9-95CC-74BCFD0CCC8DQ30995133-C2F6D152-BA87-4E9D-9334-DD8BFE6722A6Q31126151-BBE25969-D420-4CDF-A71C-8094DB97485DQ33411580-2F7792DA-7CB3-4B0E-9B9A-6E3A368F66B8Q33430011-9C12DDFD-CA16-49A4-874E-E94CB33B1457Q33516563-D2C07104-6522-4612-A394-EA48F4AFB3F1Q33630671-F472CBEC-B60B-41C5-B665-E20A0F3C7E15Q33657123-984E9CF3-1058-417B-8F40-6E3E27754F84Q33683683-7E0EDD6A-124D-4136-93CB-ADFC7203A433Q33714041-3291295F-1544-4240-A2A7-6FE9A59A2147Q33721892-E65C7C28-815B-47A9-BC88-234ED511050CQ33728623-090C13E7-C93B-4E3A-84E6-255C2FA785C1Q33817234-C42F1395-1B08-49D0-9744-C90CDBA7CD30Q33817443-4DFEAC9D-6FE6-47A7-885F-0AB8AEFA2CEF
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Quique Bassat
@ast
Quique Bassat
@en
Quique Bassat
@es
Quique Bassat
@nl
Quique Bassat
@pt
Quique Bassat
@sl
type
label
Quique Bassat
@ast
Quique Bassat
@en
Quique Bassat
@es
Quique Bassat
@nl
Quique Bassat
@pt
Quique Bassat
@sl
prefLabel
Quique Bassat
@ast
Quique Bassat
@en
Quique Bassat
@es
Quique Bassat
@nl
Quique Bassat
@pt
Quique Bassat
@sl
P1053
P-2341-2016
P106
P21
P31
P3829
P496
0000-0003-0875-7596
P569
2000-01-01T00:00:00Z